Copyright Reports & Markets. All rights reserved.

Global Antipyretic Analgesics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antipyretic Analgesics Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Paracetamol
    • 1.3.3 Aspirin
    • 1.3.4 Ibuprofen
    • 1.3.5 Naproxen
    • 1.3.6 Diclofenac
    • 1.3.7 Oxaprozin
    • 1.3.8 Dexibuprofen
    • 1.3.9 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antipyretic Analgesics Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Adults
    • 1.4.3 Children
  • 1.5 Global Antipyretic Analgesics Market Size & Forecast
    • 1.5.1 Global Antipyretic Analgesics Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Antipyretic Analgesics Sales Quantity (2021-2032)
    • 1.5.3 Global Antipyretic Analgesics Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Mallinckrodt Pharmaceuticals
    • 2.1.1 Mallinckrodt Pharmaceuticals Details
    • 2.1.2 Mallinckrodt Pharmaceuticals Major Business
    • 2.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product and Services
    • 2.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
  • 2.2 IOL
    • 2.2.1 IOL Details
    • 2.2.2 IOL Major Business
    • 2.2.3 IOL Antipyretic Analgesics Product and Services
    • 2.2.4 IOL Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 IOL Recent Developments/Updates
  • 2.3 Anqiu Lu'an Pharmaceutical
    • 2.3.1 Anqiu Lu'an Pharmaceutical Details
    • 2.3.2 Anqiu Lu'an Pharmaceutical Major Business
    • 2.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product and Services
    • 2.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
  • 2.4 Novacyl
    • 2.4.1 Novacyl Details
    • 2.4.2 Novacyl Major Business
    • 2.4.3 Novacyl Antipyretic Analgesics Product and Services
    • 2.4.4 Novacyl Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Novacyl Recent Developments/Updates
  • 2.5 BASF
    • 2.5.1 BASF Details
    • 2.5.2 BASF Major Business
    • 2.5.3 BASF Antipyretic Analgesics Product and Services
    • 2.5.4 BASF Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BASF Recent Developments/Updates
  • 2.6 Anhui BBCA Pharmaceuticals
    • 2.6.1 Anhui BBCA Pharmaceuticals Details
    • 2.6.2 Anhui BBCA Pharmaceuticals Major Business
    • 2.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product and Services
    • 2.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Anhui BBCA Pharmaceuticals Recent Developments/Updates
  • 2.7 Hubei Biocause
    • 2.7.1 Hubei Biocause Details
    • 2.7.2 Hubei Biocause Major Business
    • 2.7.3 Hubei Biocause Antipyretic Analgesics Product and Services
    • 2.7.4 Hubei Biocause Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hubei Biocause Recent Developments/Updates
  • 2.8 Xinhua Pharm
    • 2.8.1 Xinhua Pharm Details
    • 2.8.2 Xinhua Pharm Major Business
    • 2.8.3 Xinhua Pharm Antipyretic Analgesics Product and Services
    • 2.8.4 Xinhua Pharm Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Xinhua Pharm Recent Developments/Updates
  • 2.9 Granules India Limited
    • 2.9.1 Granules India Limited Details
    • 2.9.2 Granules India Limited Major Business
    • 2.9.3 Granules India Limited Antipyretic Analgesics Product and Services
    • 2.9.4 Granules India Limited Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Granules India Limited Recent Developments/Updates
  • 2.10 Huagang Pharm
    • 2.10.1 Huagang Pharm Details
    • 2.10.2 Huagang Pharm Major Business
    • 2.10.3 Huagang Pharm Antipyretic Analgesics Product and Services
    • 2.10.4 Huagang Pharm Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Huagang Pharm Recent Developments/Updates
  • 2.11 Hebei Jiheng Pharmaceutical
    • 2.11.1 Hebei Jiheng Pharmaceutical Details
    • 2.11.2 Hebei Jiheng Pharmaceutical Major Business
    • 2.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product and Services
    • 2.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
  • 2.12 Zhejiang Kangle Pharmaceutical
    • 2.12.1 Zhejiang Kangle Pharmaceutical Details
    • 2.12.2 Zhejiang Kangle Pharmaceutical Major Business
    • 2.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product and Services
    • 2.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
  • 2.13 Hebei Jingye Medical Technology
    • 2.13.1 Hebei Jingye Medical Technology Details
    • 2.13.2 Hebei Jingye Medical Technology Major Business
    • 2.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Product and Services
    • 2.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
  • 2.14 MSPF
    • 2.14.1 MSPF Details
    • 2.14.2 MSPF Major Business
    • 2.14.3 MSPF Antipyretic Analgesics Product and Services
    • 2.14.4 MSPF Antipyretic Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 MSPF Recent Developments/Updates

3 Competitive Environment: Antipyretic Analgesics by Manufacturer

  • 3.1 Global Antipyretic Analgesics Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Antipyretic Analgesics Revenue by Manufacturer (2021-2026)
  • 3.3 Global Antipyretic Analgesics Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Antipyretic Analgesics by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Antipyretic Analgesics Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Antipyretic Analgesics Manufacturer Market Share in 2025
  • 3.5 Antipyretic Analgesics Market: Overall Company Footprint Analysis
    • 3.5.1 Antipyretic Analgesics Market: Region Footprint
    • 3.5.2 Antipyretic Analgesics Market: Company Product Type Footprint
    • 3.5.3 Antipyretic Analgesics Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antipyretic Analgesics Market Size by Region
    • 4.1.1 Global Antipyretic Analgesics Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Antipyretic Analgesics Consumption Value by Region (2021-2032)
    • 4.1.3 Global Antipyretic Analgesics Average Price by Region (2021-2032)
  • 4.2 North America Antipyretic Analgesics Consumption Value (2021-2032)
  • 4.3 Europe Antipyretic Analgesics Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Antipyretic Analgesics Consumption Value (2021-2032)
  • 4.5 South America Antipyretic Analgesics Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Antipyretic Analgesics Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Antipyretic Analgesics Sales Quantity by Type (2021-2032)
  • 5.2 Global Antipyretic Analgesics Consumption Value by Type (2021-2032)
  • 5.3 Global Antipyretic Analgesics Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Antipyretic Analgesics Sales Quantity by Application (2021-2032)
  • 6.2 Global Antipyretic Analgesics Consumption Value by Application (2021-2032)
  • 6.3 Global Antipyretic Analgesics Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Antipyretic Analgesics Sales Quantity by Type (2021-2032)
  • 7.2 North America Antipyretic Analgesics Sales Quantity by Application (2021-2032)
  • 7.3 North America Antipyretic Analgesics Market Size by Country
    • 7.3.1 North America Antipyretic Analgesics Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Antipyretic Analgesics Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Antipyretic Analgesics Sales Quantity by Type (2021-2032)
  • 8.2 Europe Antipyretic Analgesics Sales Quantity by Application (2021-2032)
  • 8.3 Europe Antipyretic Analgesics Market Size by Country
    • 8.3.1 Europe Antipyretic Analgesics Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Antipyretic Analgesics Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antipyretic Analgesics Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Antipyretic Analgesics Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Antipyretic Analgesics Market Size by Region
    • 9.3.1 Asia-Pacific Antipyretic Analgesics Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Antipyretic Analgesics Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Antipyretic Analgesics Sales Quantity by Type (2021-2032)
  • 10.2 South America Antipyretic Analgesics Sales Quantity by Application (2021-2032)
  • 10.3 South America Antipyretic Analgesics Market Size by Country
    • 10.3.1 South America Antipyretic Analgesics Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Antipyretic Analgesics Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antipyretic Analgesics Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Antipyretic Analgesics Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Antipyretic Analgesics Market Size by Country
    • 11.3.1 Middle East & Africa Antipyretic Analgesics Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Antipyretic Analgesics Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Antipyretic Analgesics Market Drivers
  • 12.2 Antipyretic Analgesics Market Restraints
  • 12.3 Antipyretic Analgesics Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antipyretic Analgesics and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antipyretic Analgesics
  • 13.3 Antipyretic Analgesics Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antipyretic Analgesics Typical Distributors
  • 14.3 Antipyretic Analgesics Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antipyretic Analgesics market size was valued at US$ 2962 million in 2025 and is forecast to a readjusted size of US$ 3211 million by 2032 with a CAGR of 1.2% during review period.
    Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
    From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
    Antipyretic analgesic of the world"s main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.
    This report is a detailed and comprehensive analysis for global Antipyretic Analgesics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Antipyretic Analgesics market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2021-2032
    Global Antipyretic Analgesics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2021-2032
    Global Antipyretic Analgesics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2021-2032
    Global Antipyretic Analgesics market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Antipyretic Analgesics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Antipyretic Analgesics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm, Granules India Limited, Huagang Pharm, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Antipyretic Analgesics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Paracetamol
    Aspirin
    Ibuprofen
    Naproxen
    Diclofenac
    Oxaprozin
    Dexibuprofen
    Others
    Market segment by Application
    Adults
    Children
    Major players covered
    Mallinckrodt Pharmaceuticals
    IOL
    Anqiu Lu'an Pharmaceutical
    Novacyl
    BASF
    Anhui BBCA Pharmaceuticals
    Hubei Biocause
    Xinhua Pharm
    Granules India Limited
    Huagang Pharm
    Hebei Jiheng Pharmaceutical
    Zhejiang Kangle Pharmaceutical
    Hebei Jingye Medical Technology
    MSPF
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Antipyretic Analgesics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Antipyretic Analgesics, with price, sales quantity, revenue, and global market share of Antipyretic Analgesics from 2021 to 2026.
    Chapter 3, the Antipyretic Analgesics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Antipyretic Analgesics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Antipyretic Analgesics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Antipyretic Analgesics.
    Chapter 14 and 15, to describe Antipyretic Analgesics sales channel, distributors, customers, research findings and conclusion.

    Buy now